<p>美国市场在过去一周保持平稳，但在过去一年中显著上涨了 30%，预计年收益增长将达到 16%。在这样的环境下，内部持股比例高的成长型公司尤其吸引人，因为它们通常表明内部信心强烈，并与股东利益保持一致。</p>
<h3>美国内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>优信 (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们快速增长的美国内部持股比例高的 203 只股票的完整列表。</p>
<p>在这里，我们突出显示了我们筛选器中一些首选股票的子集。</p>
<h2>Viemed Healthcare (VMD)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Viemed Healthcare, Inc. 在美国运营，提供家庭医疗设备和急性后呼吸健康服务，市值为 3.729 亿美元。</p>
<p><strong>运营：</strong> 该公司从其医疗设施与服务部门产生的收入为 2.7028 亿美元。</p>
<p><strong>内部持股比例：</strong> 13.6%</p>
<p><strong>收益增长预测：</strong> 每年 27.8%。</p>
<p>Viemed Healthcare 展现出作为一家内部持股比例高的成长型公司的潜力，过去一年其收益增长达到 32.6%，预计年收入增长为 12.8%，超过美国市场平均水平。该公司在最近的公告中强调了其对有机增长和有纪律的收购的战略重点。此外，Viemed 的新股票回购计划进一步表明了对其估值的信心，尽管最近没有实质性的内部交易，其交易价格显著低于估计的公允价值。</p>
<ul>
<li>在这里深入了解 Viemed Healthcare 的具体情况，查看我们的详细增长预测报告。</li>
<li>我们的估值报告揭示了 Viemed Healthcare 的股票可能在折扣交易。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 4 月的 VMD 收益和收入增长</p>
<h2>Ramaco Resources (METC)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Ramaco Resources, Inc. 从事冶金煤的开发、运营和销售，市值为 8.8658 亿美元。</p>
<p><strong>运营：</strong> 该公司的收入完全来自冶金煤部门，总计 5.3662 亿美元。</p>
<p><strong>内部持股比例：</strong> 10.4%</p>
<p><strong>收益增长预测：</strong> 每年 93.4%。</p>
<p>Ramaco Resources 面临挑战，预计 2025 年净亏损为 5145 万美元，较前一年的净收入 1119 万美元下降，销售数字也在下降。尽管面临这些挫折，该公司交易价格显著低于其估计的公允价值，预计在三年内将实现盈利，收益增长预测为每年 93.39%。然而，与集体诉讼相关的法律问题可能会影响投资者情绪，尽管最近没有内部交易活动。</p>
<ul>
<li>点击这里发现 Ramaco Resources 的细微差别，查看我们的详细分析未来增长报告。</li>
<li>根据我们的估值报告，Ramaco Resources 的股价可能偏低。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 4 月的 METC 收益和收入增长</p>
<h2>优信 (UXIN)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 优信有限公司是一家投资控股公司，在中华人民共和国作为二手车零售商运营，市值约为 6 亿美元。</p>
<p><strong>运营：</strong> 该公司主要从其互联网信息提供商部门产生的收入，总计为 32.4 亿人民币。</p>
<p><strong>内部持股比例：</strong> 35.7%</p>
<p><strong>收益增长预测：</strong> 每年 74.1%。</p>
<p>优信的增长轨迹得益于战略扩张和高水平的内部持股，这使管理层的利益与股东保持一致。该公司报告 2025 年显著的收入增长，达到 32.4 亿人民币，同时将净亏损缩小至 2.7754 亿人民币。优信预计年收入增长为 36%，超过美国市场平均水平，并支持其在三年内的盈利前景。最近的领导层变动和战略合作伙伴关系进一步增强了其在中国汽车行业的扩张。</p>
<ul>
<li>在我们的收益增长报告中更深入地了解优信的潜力。</li>
<li>我们最近的估值报告指出，优信的股票在市场上可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown"/></p>
<p>截至 2026 年 4 月的 UXIN 持股分布</p>
<h2>利用机会</h2>
<ul>
<li>解锁更多宝藏！我们的快速增长的美国内部持股比例高的公司筛选器为您挖掘了 200 家更多公司供您探索。点击这里揭示我们精心策划的 203 家快速增长的美国内部持股比例高的公司的列表。</li>
<li>考虑其他策略？人工智能即将改变医疗保健。这 124 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——仍然有时间提前布局。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
<h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
<p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
<p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

METCB

METC

优信

<p>美国市场在过去一年中增长了 30%，预计年收益将增长 16%。拥有高内部持股的成长型公司颇具吸引力，表明内部信心强烈。值得注意的公司包括优信（35.7% 内部持股，74.1% 收益增长）、Ramaco Resources（10.4% 内部持股，93.4% 收益增长）和 Viemed Healthcare（13.6% 内部持股，27.8% 收益增长）。尽管面临不同的挑战，这些公司显示出增长潜力，内部持股将管理层利益与股东利益对齐</p>

<p>The United States market remained flat over the last week but has seen a notable 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.</p>
<div class="lb-trans"><p>美国市场在过去一周保持平稳，但在过去一年中显著上涨了 30%，预计年收益增长将达到 16%。在这样的环境下，内部持股比例高的成长型公司尤其吸引人，因为它们通常表明内部信心强烈，并与股东利益保持一致。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3>
<div class="lb-trans"><h3>美国内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Uxin (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>优信 (UXIN)</td>
<td>35.7%</td>
<td>74.1%</td>
</tr>
<tr>
<td>Upstart Holdings (UPST)</td>
<td>12.8%</td>
<td>53.6%</td>
</tr>
<tr>
<td>Precigen (PGEN)</td>
<td>11.9%</td>
<td>68.4%</td>
</tr>
<tr>
<td>Karman Holdings (KRMN)</td>
<td>17%</td>
<td>53.2%</td>
</tr>
<tr>
<td>Enovix (ENVX)</td>
<td>12.4%</td>
<td>41.1%</td>
</tr>
<tr>
<td>Clene (CLNN)</td>
<td>12%</td>
<td>62.2%</td>
</tr>
<tr>
<td>Caledonia Mining (CMCL)</td>
<td>14.3%</td>
<td>29.6%</td>
</tr>
<tr>
<td>Better Home &amp; Finance Holding (BETR)</td>
<td>19.3%</td>
<td>104%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.8%</td>
<td>27.8%</td>
</tr>
<tr>
<td>AppLovin (APP)</td>
<td>27.4%</td>
<td>22.1%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 203 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们快速增长的美国内部持股比例高的 203 只股票的完整列表。</p>
</div><p>Here we highlight a subset of our preferred stocks from the screener.</p>
<div class="lb-trans"><p>在这里，我们突出显示了我们筛选器中一些首选股票的子集。</p>
</div><h2>Viemed Healthcare (VMD)</h2>
<div class="lb-trans"><h2>Viemed Healthcare (VMD)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Viemed Healthcare, Inc. operates in the United States offering home medical equipment and post-acute respiratory healthcare services, with a market cap of $372.90 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Viemed Healthcare, Inc. 在美国运营，提供家庭医疗设备和急性后呼吸健康服务，市值为 3.729 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of $270.28 million from its Healthcare Facilities &amp; Services segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从其医疗设施与服务部门产生的收入为 2.7028 亿美元。</p>
</div><p><strong>Insider Ownership:</strong> 13.6%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 13.6%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 27.8% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 27.8%。</p>
</div><p>Viemed Healthcare demonstrates potential as a growth company with high insider ownership, evidenced by its robust earnings growth of 32.6% over the past year and forecasted revenue increase of 12.8% annually, surpassing the US market average. The company's strategic focus on organic growth and disciplined acquisitions was highlighted in recent announcements. Additionally, Viemed's new share repurchase program underscores confidence in its valuation, trading significantly below estimated fair value despite no substantial insider buying recently.</p>
<div class="lb-trans"><p>Viemed Healthcare 展现出作为一家内部持股比例高的成长型公司的潜力，过去一年其收益增长达到 32.6%，预计年收入增长为 12.8%，超过美国市场平均水平。该公司在最近的公告中强调了其对有机增长和有纪律的收购的战略重点。此外，Viemed 的新股票回购计划进一步表明了对其估值的信心，尽管最近没有实质性的内部交易，其交易价格显著低于估计的公允价值。</p>
</div><ul>
<li>Dive into the specifics of Viemed Healthcare here with our thorough growth forecast report.</li>
<li>Our valuation report unveils the possibility Viemed Healthcare's shares may be trading at a discount.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解 Viemed Healthcare 的具体情况，查看我们的详细增长预测报告。</li>
<li>我们的估值报告揭示了 Viemed Healthcare 的股票可能在折扣交易。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/a2a6ac4a-d3ae-4743-a8ab-bf92331843a7/chart/earnings-and-revenue-growth"/></p>
<p>VMD Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 VMD 收益和收入增长</p>
</div><h2>Ramaco Resources (METC)</h2>
<div class="lb-trans"><h2>Ramaco Resources (METC)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Ramaco Resources, Inc. is involved in the development, operation, and sale of metallurgical coal with a market cap of $886.58 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Ramaco Resources, Inc. 从事冶金煤的开发、运营和销售，市值为 8.8658 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived entirely from the metallurgical coal segment, totaling $536.62 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入完全来自冶金煤部门，总计 5.3662 亿美元。</p>
</div><p><strong>Insider Ownership:</strong> 10.4%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 10.4%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 93.4% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 93.4%。</p>
</div><p>Ramaco Resources faces challenges with a net loss of US$51.45 million for 2025, down from a net income of US$11.19 million the previous year, and declining sales figures. Despite these setbacks, the company is trading significantly below its estimated fair value and is expected to become profitable within three years with earnings growth forecasted at 93.39% annually. However, legal issues related to class action lawsuits could impact investor sentiment despite no recent insider trading activity.</p>
<div class="lb-trans"><p>Ramaco Resources 面临挑战，预计 2025 年净亏损为 5145 万美元，较前一年的净收入 1119 万美元下降，销售数字也在下降。尽管面临这些挫折，该公司交易价格显著低于其估计的公允价值，预计在三年内将实现盈利，收益增长预测为每年 93.39%。然而，与集体诉讼相关的法律问题可能会影响投资者情绪，尽管最近没有内部交易活动。</p>
</div><ul>
<li>Click here to discover the nuances of Ramaco Resources with our detailed analytical future growth report.</li>
<li>According our valuation report, there's an indication that Ramaco Resources' share price might be on the cheaper side.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里发现 Ramaco Resources 的细微差别，查看我们的详细分析未来增长报告。</li>
<li>根据我们的估值报告，Ramaco Resources 的股价可能偏低。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/b401923f-33a5-4c09-8deb-b067999fa26b/chart/earnings-and-revenue-growth"/></p>
<p>METC Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 METC 收益和收入增长</p>
</div><h2>Uxin (UXIN)</h2>
<div class="lb-trans"><h2>优信 (UXIN)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Uxin Limited is an investment holding company that operates as a used car retailer in the People's Republic of China, with a market cap of approximately $600 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> 优信有限公司是一家投资控股公司，在中华人民共和国作为二手车零售商运营，市值约为 6 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its Internet Information Providers segment, amounting to CN¥3.24 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要从其互联网信息提供商部门产生的收入，总计为 32.4 亿人民币。</p>
</div><p><strong>Insider Ownership:</strong> 35.7%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 35.7%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 74.1% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 74.1%。</p>
</div><p>Uxin's growth trajectory is underpinned by strategic expansions and a high level of insider ownership, which aligns management interests with shareholders. The company reported significant revenue growth for 2025, reaching CNY 3.24 billion, while narrowing its net loss to CNY 277.54 million. Uxin's forecasted annual revenue growth of 36% outpaces the US market average and supports its profitability outlook within three years. Recent leadership changes and strategic partnerships further bolster its expansion in China's automotive sector.</p>
<div class="lb-trans"><p>优信的增长轨迹得益于战略扩张和高水平的内部持股，这使管理层的利益与股东保持一致。该公司报告 2025 年显著的收入增长，达到 32.4 亿人民币，同时将净亏损缩小至 2.7754 亿人民币。优信预计年收入增长为 36%，超过美国市场平均水平，并支持其在三年内的盈利前景。最近的领导层变动和战略合作伙伴关系进一步增强了其在中国汽车行业的扩张。</p>
</div><ul>
<li>Take a closer look at Uxin's potential here in our earnings growth report.</li>
<li>Insights from our recent valuation report point to the potential overvaluation of Uxin shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的收益增长报告中更深入地了解优信的潜力。</li>
<li>我们最近的估值报告指出，优信的股票在市场上可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/d97cef4a-c4c1-4304-9530-9f3d25d77741/chart/ownership-breakdown"/></p>
<p>UXIN Ownership Breakdown as at Apr 2026</p>
<div class="lb-trans"><p>截至 2026 年 4 月的 UXIN 持股分布</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Unlock more gems! Our Fast Growing US Companies With High Insider Ownership screener has unearthed 200 more companies for you to explore.Click here to unveil our expertly curated list of 203 Fast Growing US Companies With High Insider Ownership.</li>
<li>Contemplating Other Strategies? AI is about to change healthcare. These 124 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁更多宝藏！我们的快速增长的美国内部持股比例高的公司筛选器为您挖掘了 200 家更多公司供您探索。点击这里揭示我们精心策划的 203 家快速增长的美国内部持股比例高的公司的列表。</li>
<li>考虑其他策略？人工智能即将改变医疗保健。这 124 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——仍然有时间提前布局。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

三家内部人士偏爱的高持股增长公司